THREE YEARS OF ENTECAVIR (ETV) RE-TREATMENT OF HBEAG(-) ETV PATIENTS WHO PREVIOUSLY DISCONTINUED ETV TREATMENT: RESULTS FROM STUDY ETV-901

被引:0
|
作者
Shouval, Daniel [1 ]
Lai, Ching-Lung [2 ]
Chang, Ting-Tsung [3 ]
Gadano, Adrian [4 ]
Wu, Shun-Sheng [5 ]
Halota, Waldemar [6 ]
Sievert, William [7 ]
Tsai, Naoky C. S. C. [8 ]
Zhang, Hui [9 ]
Iloeje, Uchenna [9 ]
机构
[1] Hadassah Med Org, Liver Unit, Jerusalem, Israel
[2] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan
[4] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[5] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan
[6] Klin Chorob Zakaznych AM, Bydgoszcz, Poland
[7] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[8] Univ Hawaii, Honolulu, HI 96822 USA
[9] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
927
引用
收藏
页码:722A / 723A
页数:2
相关论文
共 50 条
  • [31] Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(-) chronic hepatitis B patients (Study ETV-027)
    Lai, Ching-Lung
    Chang, Ting-Tsung
    Chao, You-Chen
    Tanwandee, Tawesak
    Thongsawat, Satawat
    Lee, Shou-Dong
    Angus, Peter
    Zink, Richard
    Zhu, Jin
    Brett-Smith, Helena
    Neo, Boon-Leong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A128 - A128
  • [32] Entecavir is superior to continued lamivudine for the treatment of lamivudine-refractory, HBeAg(+) chronic hepatitis B: results of Phase III study ETV-026
    Sherman, M
    Yurdaydin, C
    Sollano, J
    Silva, M
    Goodman, Z
    Chen, L
    Cross, A
    DeHertogh, D
    Hindes, R
    ANTIVIRAL THERAPY, 2004, 9 (06) : H22 - H23
  • [33] Detection of entecavir-resistant (ETV-R) mutations in nucleoside-naive and in lamivudine-refractory (Lvd-R) HBV patients and implications on response to ETV treatment
    Degertekin, Bulent
    Hussain, Munira T.
    Oberhelman, Kelly
    Fontana, Robert J.
    Marrero, Jorge A.
    Conjeevaram, Hari S.
    Kang, Hellan
    Lok, Anna S.
    GASTROENTEROLOGY, 2008, 134 (04) : A807 - A807
  • [34] HISTOLOGIC ASSESSMENT OF LONG-TERM ENTECAVIR (ETV) TREATMENT IN CHRONIC HEPATITIS B (CHB) PATIENTS
    Katano, Yoshiaki
    Kumada, Hiromitsu
    Kobashi, Haruhiko
    Toyoto, Joji
    Yokosuka, Osamu
    Takaguchi, Koichi
    Kage, Masayoshi
    Moriyama, Mitsuhiko
    Imozeki, Furnio
    Ishikawa, Hiroki
    Seriu, Toku
    Omota, Masao
    HEPATOLOGY, 2008, 48 (04) : 703A - 704A
  • [35] TREATMENT OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) AND PARTIAL RESPONSE TO ADEFOVIR (ADV) WHO WERE SWITCHED TO ENTECAVIR (ETV)
    Nguyen, Mindie H.
    Trinh, Huy N.
    Garcio, Ruel T.
    Nguyen, Long H.
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Levitt, Brian S.
    HEPATOLOGY, 2008, 48 (04) : 711A - 711A
  • [36] Entecavir (ETV) results in early viral load reduction in chronic hepatitis B (CHB) patients who have failed lamivudine (LVD) therapy: a randomized, placebo-controlled study in China (study ETV-056)
    Yao, Guangbi
    Zhou, X.
    Xu, Daozheng
    Wang, B.
    Ren, Hong
    Jiang, Michael
    Liu, Jessica
    Xu, Dong
    Macdonald, Laurie
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A127 - A127
  • [37] HBeAg seroconversion is lower in Asian versus non-Asian patients during treatment of chronic hepatitis B with tenofovir (TDF) or entecavir (ETV)
    Jo, Kahee
    Dodge, Jennifer L.
    Wadley, Adrian
    Wakil, Adil E.
    Baron, Jody L.
    Cooper, Stewart
    HEPATOLOGY, 2013, 58 : 669A - 670A
  • [38] Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or Relapse Off-Treatment
    Lai, Ching-Lung
    Elion, Richard A.
    Sherman, Morris
    Hann, Hie-Won
    Tyrrell, D. Lome J.
    Hsu, Chao Wei
    Tan, Chee-Kiat
    Peng, Cheng-Yuan
    Leung, Nancy
    Mencarini, Kimberly A.
    Zhang, Hui
    Iloeje, Uchenna H.
    Kreter, Bruce
    GASTROENTEROLOGY, 2009, 136 (05) : A868 - A868
  • [39] ENTECAVIR (ETV) THERAPY IN CHRONIC HEPATITIS B PATIENTS PREVIOUSLY TREATED WITH ADEFOVIR (ADV) WITH INCOMPLETE RESPONSE ON-TREATMENT OR RELAPSE OFF-TREATMENT
    Lai, C. L.
    Elion, R.
    Sherman, M.
    Hann, H. W.
    Tyrell, D. L.
    Hsu, C. W.
    Tan, C. K.
    Peng, C. Y.
    Leung, N.
    Mercarni, K.
    Zhang, H.
    Iloeje, U. H.
    Kreter, B.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S334 - S334
  • [40] COMPLETE VIRAL SUPPRESSION (CVS) AND ALT NORMALIZATION ON ENTECAVIR (ETV) THERAPY IN PATIENTS WHO WERE PREVIOUSLY TREATED WITH ADEFOVIR (ADV): A MULTICENTER STUDY
    Nguyen, Mindie H.
    Trinh, Huy N.
    Nguyen, Thuan
    Do, Son T.
    Tran, Phuong
    Nguyen, Khanh K.
    Nguyen, Huy A.
    Nguyen, Nghia H.
    Garcia, Ruel T.
    HEPATOLOGY, 2009, 50 (04) : 540A - 541A